Back to video list Back to Home Which patients should receive a monoclonal antibody for migraine prevention and the implications of medication overuse You may also like Schizophrenia Article Treatment-resistant schizophrenia — mechanisms, awareness, and economic burden Depression Bipolar Article Predicting vulnerability to mood disorders and treatment response Parkinson's Disease Article The Shaking Palsy Migraine Satellite symposium Article What can be done to lower the economic cost of migraine?